Literature DB >> 1097154

Bioavailability of oral dexamethasone.

D E Duggan, K C Yeh, N Matalia, C A Ditzler, F G McMahon.   

Abstract

Bioavailabilities of dexamethasone tablets and elixir in man were evaluated by each of 3 model-independent methods of pharmacokinetic analysis employing plasma and urinary values as determined by radioimmune assay. There were no significant differences among the results determined by the 3 methods nor between the respective availabilities of the two formulations; the latter averaged 82.6 +/- 17.7% for the elixir formulation and 78.0 +/- 12.1% for tablets.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097154     DOI: 10.1002/cpt1975182205

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

Review 1.  Pharmacokinetic optimisation of antiemetic therapy.

Authors:  M Campbell; D N Bateman
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

2.  Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells.

Authors:  Hideki Kimura; Xuan Li; Kunio Torii; Toshiharu Okada; Kazuko Kamiyama; Daisuke Mikami; Kenji Kasuno; Naoki Takahashi; Haruyoshi Yoshida
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

3.  The pharmacokinetics of low-dose dexamethasone in congenital adrenal hyperplasia.

Authors:  M C Young; N Cook; G F Read; I A Hughes
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia.

Authors:  Simone M C Spoorenberg; Vera H M Deneer; Jan C Grutters; Astrid E Pulles; G P Paul Voorn; Ger T Rijkers; Willem Jan W Bos; Ewoudt M W van de Garde
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

5.  Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells.

Authors:  H P Rutz; M Mariotta; M von Knebel Doeberitz; R O Mirimanoff
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

6.  Dose-dependent pharmacokinetics of dexamethasone.

Authors:  D Loew; O Schuster; E H Graul
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

8.  Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the rat.

Authors:  M A Kassem; K E Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

Review 9.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

10.  The effect of in vitro and in vivo dexamethasone on human neutrophil function.

Authors:  D A Lomas; M Ip; A Chamba; R A Stockley
Journal:  Agents Actions       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.